Previous Section
Review Articles
1. Dual tyrosine kinase inhibitors in chronic myeloid leukemia.
- Author
- Martinelli G; Soverini S; Rosti G; Baccarani M;
- Institution
- Institute of Hematology and Medical Oncology Seragnoli, University of Bologna, Bologna, Italy. gmartino@kaiser.alma.unibo.it
- Journal
- Leukemia. 2005 Nov;19(11):1872-9.
- Abstract URL
- Click here to view abstract
2. Autologous stem cell transplantation in chronic myeloid leukaemia: a meta-analysis of six randomized trials.
- Author
- Institution
- CTSU, Richard Doll Building, Old Road Campus, Roosevelt Drive, Oxford OX3 7LF, UK. cmloverview@ctsu.ox.ac.uk
- Journal
- Cancer Treat Rev. 2007 Feb;33(1):39-47. Epub 2006 Dec 11.
- Abstract URL
- Click here to view abstract
3. Treatment of chronic myeloid leukemia with imatinib mesylate.
- Author
- Ohno R;
- Institution
- Aichi Cancer Center and Aichi Syukutoku University, 1-1 Kanokoden, Chikusa-ku, Nagoya, 464-8681, Japan. ohnoryu@aichi-cc.jp
- Journal
- Int J Clin Oncol. 2006 Jun;11(3):176-83.
- Abstract URL
- Click here to view abstract
4. Chronic myeloid leukemia: diagnosis and treatment.
- Author
- Quintas-Cardama A; Cortes JE;
- Institution
- Department of Leukemia, The University of Texas, M. D. Anderson Cancer Center, Houston, Tex 77030, USA.
- Journal
- Mayo Clin Proc. 2006 Jul;81(7):973-88.
- Abstract URL
- Click here to view abstract
5. New strategies in chronic myeloid leukemia.
- Author
- Kantarjian HM; Cortes J;
- Institution
- Department of Leukemia, The University of Texas, M. D. Anderson Cancer Center, Houston, Texas 77030, USA. hkantarj@mdanderson.org
- Journal
- Int J Hematol. 2006 May;83(4):289-93.
- Abstract URL
- Click here to view abstract
6. New targeted approaches in chronic myeloid leukemia.
- Author
- Cortes J; Kantarjian H;
- Institution
- Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Unit 428, Houston, TX 77030, USA. jcortes@mdanderson.org
- Journal
- J Clin Oncol. 2005 Sep 10;23(26):6316-24.
- Abstract URL
- Click here to view abstract
7. Stem cell transplantation in patients with chronic myelogenous leukemia: when should it be used?
- Author
- Mauro MJ; Maziarz RT;
- Institution
- Center for Hematologic Malignancies, Oregon Cancer Institute, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, UHN73C, Portland, OR 97239, USA. maurom@ohsu.edu
- Journal
- Mayo Clin Proc. 2006 Mar;81(3):404-16.
- Abstract URL
- Click here to view abstract
8. Targeted CML therapy: controlling drug resistance, seeking cure.
- Author
- O'Hare T; Corbin AS; Druker BJ;
- Institution
- Howard Hughes Medical Institute, Oregon Health & Science University Cancer Institute, L592, 3181 SW Sam Jackson Park Road, Portland, OR 97239, USA.
- Journal
- Curr Opin Genet Dev. 2006 Feb;16(1):92-9. Epub 2005 Dec 15.
- Abstract URL
- Click here to view abstract
9. Targeted therapy in chronic myeloid leukemia.
- Author
- Jabbour E; Cortes JE; Ghanem H; O'Brien S; Kantarjian HM;
- Institution
- The University of Texas MD Anderson Cancer Center, Department of Leukemia, Unit 428, 1515 Holcombe Blvd, Houston, TX 77030, USA. ejabbour@mdanderson.org
- Journal
- Expert Rev Anticancer Ther. 2008 Jan;8(1):99-110.
- Abstract URL
- Click here to view abstract
10. Strategies for overcoming imatinib resistance in chronic myeloid leukemia.
- Author
- Kujawski L; Talpaz M;
- Institution
- Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan 48109-0843, USA. kuj@med.umich.edu
- Journal
- Leuk Lymphoma. 2007 Dec;48(12):2310-22.
- Abstract URL
- Click here to view abstract
